Seven Bridges is the leading biomedical data science company.
Seven Bridges is the industry-leading infrastructure and data analytics company accelerating precision medicine by enabling the understanding of biomedical data. Our platform, services, and support expertise are driving discovery and drug development at the world’s leading academic, biotechnology, government, hospitals, and pharmaceutical entities. Through our collaborations with the largest genomics projects, we connect the world’s biomedical information to enable the most efficient analysis at scale. Named one of the world's smartest companies by MIT Technology Review, and a three-time Bio-IT World Best of Show winner, Seven Bridges has offices in Belgrade, Boston, Istanbul, and San Francisco.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 27, 2021 | Series C | $15M | — | — | — | Detail |
Apr 2, 2018 | Series B | $50M | — | — | — | Detail |
Feb 16, 2016 | Series A | $45M | 1 | Kryssen Capital | — | Detail |
Sep 1, 2014 | Seed | $3M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Kryssen Capital | Yes | Series A |
First Star Ventures | — | Seed |